The Mediastinal Mass: A Multidisciplinary Approach

Tumors of the mediastinum are usually diagnosed in young patients, but they can develop at any age and form any tissue that exists in or passes through the chest cavity. The diagnosis and the accurate assessment of the mediastinum masses represents a challenge, given their clinical variability from asymptomatic to producing symptoms of cough, chest pain, and dyspnea. Mediastinal tumors encompass a wide range of various neoplasms. The localization of mediastinal masses is critical in the diagnosis: the anterior mediastinal masses are generally thymomas, teratomas, substernal thyroid/parathyroid tissue, or lymphomas; the middle mediastinum massess are typically pericardial and bronchogenic cysts; the posterior mediastinum  masses are often neurogenic tumors and esophageal cysts. The wide variety of different entities demonstrates a heterogeneous spectrum of clinical and pathologic features, suggesting that a uniform “standard” management of these patients is not appropriate.   
In this context, the proposed book will provide a comprehensive review of the mediastinal tumors according to different sites of the diseases, including the masses of anterior, middle and posterior mediastinum. The handling of these tumors requires a multidisciplinary approach due to the complex anatomy of the mediastinum as well as the different clinical, radiographic, and prognostic features. This book has risen from the desire to provide to the specialists in the field an easy, updated and practical guidelines title to facilitate the clinical practice of mediastinic masses. This book will be a comprehensive guide to clinical best practices developed through the opinions of experts in the field.

• Language: English
• Publisher: Humana Press
• Release date: Aug 1, 2018
• ISBN: 9783319903682

Book preview

Part IMediastinum Masses

© Springer International Publishing AG, part of Springer Nature 2018

Renato Franco, Federica Zito Marino and Antonio Giordano (eds.)The Mediastinal MassCurrent Clinical Pathologyhttps://doi.org/10.1007/978-3-319-90368-2_1

1. Introduction (Epidemiology, Mediastinal Anatomy, Mediastinal Masses)

Gerardo Botti¹   and Federica Zito Marino²  

(1)

Scientific Direction, Istituto dei Tumori ‘Fondazione G. Pascale’, Naples, Italy

(2)

Pathology Unit, Department of Mental and Physic Health and Preventive Medicine, Università della Campania ‘Luigi Vanvitelli’, Naples, Italy

Gerardo Botti (Corresponding author)

Email: [e-mail]

Email: [e-mail]

Federica Zito Marino

Keywords

Mediastinal anatomyAnterior mediastinal massesMiddle mediastinal massesPosterior mediastinal masses

Introduction

Mediastinal masses include a wide variety of tumors occurring in patients of all ages. Tumors of the mediastinum are relatively uncommon and often have overlapping histologic features, therefore representing an interesting diagnostic and therapeutic challenge. The clinical presentation of mediastinal masses can range from being asymptomatic to symptoms due to compression or direct invasion of surrounding structures. The main symptoms associated with the mediastinal tumors include cough, chest pain, and dyspnea.

Mediastinal masses represent a broad and heterogeneous histological group including neoplastic or benign, congenital or acquired, and primary or secondary lesions. Primary tumors most frequently arise from thymic, neurogenic, lymphatic, germinal, and mesenchymal tissue. Secondary mediastinal tumors are more frequent than primary, and they generally represent metastasis from primary tumors such as lung, pancreatic, gastroesophageal, and testicular cancer. The location of mediastinal tumors is critical in the differential diagnosis, since specific lesions are commonly associated to mediastinal topography [1].

Mediastinal tumors encompass a wide range of several neoplasms including thymomas, neurogenic tumors, lymphomas, germ cell neoplasms, endocrine tumors, mesenchymal tumor, and mediastinal cysts.

The broad variety of different entities demonstrates a heterogeneous spectrum of clinical and pathologic features, suggesting that a uniform standard management of these patients is not appropriate. The handle of these tumors requires a multidisciplinary approach due to the complex anatomy of the mediastinum as well as the different clinical, radiographic, and prognostic features. This book will provide an overview of the anatomy of the mediastinum as well as the different clinical, radiographic, and prognostic features and therapeutic options of the most commonly encountered masses.

Mediastinal Anatomy

The mediastinum is an anatomic space in the thoracic cavity bounded by the pleural cavities laterally, by the thoracic inlet superiorly, by the diaphragm inferiorly, by the sternum anteriorly, and by the chest wall posteriorly [2].

Historically, several different anatomic classifications of the mediastinum based upon anatomic boundaries have been proposed; to date the most used is Fraser’s scheme that subdivides into anterior, middle, and posterior compartments [2].

The anterior mediastinal compartment is bounded between the sternum and the pericardium and contains the thymus, the internal mammary vessels, the inferior sternopericardial ligament, and variable amount of fat [3].

The middle mediastinal compartment lies between the anterior and posterior compartments and includes the heart and pericardium, the ascending aorta and the aortic arch, the superior and inferior vena cava, the phrenic and the vagus nerves, and the pulmonary arteries and veins [3].

The posterior mediastinal compartment is bounded anteriorly by the pericardium and the diaphragm, posteriorly by the thoracic vertebrae, and laterally by the mediastinal pleura. It includes the esophagus, the descending thoracic aorta, the thoracic duct, the azygos venous system, the autonomic nerves, the lymph nodes, and fat [3].

The location of the masses according to different mediastinal compartment represents crucial parameters in the differential diagnosis since each tumor type has a predilection for a specific compartment.

Mediastinal Masses

Mediastinal tumors represent approximately 3% of all lesions that occur within the chest [4]. The incidence of primary mediastinal tumors are widely variable, in order of decreasing frequency neurogenic tumors (25.3%), thymomas (23.3%), followed by lymphomas (15.3%), germ cell neoplasms (12.2%), endocrine tumors (7.8%), and mesenchymal tumor (7.3%) [5].

Mediastinal tumors occur at any age; however they are most frequent in young and middle-aged adults. The frequency of primary mediastinal tumors varies with the site as well as the age; particularly in adults the most frequent are thymomas, thymic cysts, neurogenic tumors, and lymphomas, followed by germ cell tumors, enterogenous cysts, and pleuropericardial cysts. In children, the neurogenic tumors account for approximately 47% of primary mediastinal tumors; the remaining of resected masses include thymic tumors, germ cell tumors, lymphomas, enterogenous cysts, angiomas, stem cell tumors, and pleuropericardial cysts [6].

The mass location represents a critical issue in the differential diagnosis, since generally each variety of mediastinal tumor is associated with a specific compartment of recurrence (Fig. 1.1).

../images/438884_1_En_1_Chapter/438884_1_En_1_Fig1_HTML.jpg

Fig. 1.1

Mediastinal tumors associated to anatomic site of the mediastinum.

Masses in the anterior mediastinum are commonly thymomas, lymphomas, pheochromocytomas, germ cell tumors, and parathyroid lesions. Thymic tumors represent the most frequent primary tumors of the anterior mediastinum, accounting 30–50% of all lesions in this compartment [7]. Germ cell tumors account for 15% of anterior mediastinal mass es in adult and 24% in children; these compartment represents the most common extragonadal primary site of occurrence of germ cell tumors [7].

Although parathyroid adenomas are infrequently ectopic, the mediastinum is the most frequent anatomical site at which these masses may develop, particularly 80% of cases occurring in the anterior compartment [7, 8].

Lymphoma represents one of the most common tumors in mediastinum approximately 10–15% of all masses, occurring generally both in anterior and in middle compartments. Lymphomas with mediastinal involvement account for 50–70% Hodgkin’s disease and 15–25% non-Hodgkin’s [9].

Tumors of the middle mediastinum comprise predominantly mediastinal cysts, granulomatous disease, and tracheal tumors. Mediastinal cysts comprise 12–20% of all masses, including enterogenous, bronchogenic, pericardial, and metastatic cysts [8].

Masses in the posterior mediastinum are generally neurogenic tumors, esophageal tumors, and neurenteric cyst. Neurogenic tumors represent 95% of posterior mediastinal tumors; they are classified according to cell type [10].

References

1.

Wright CD, Mathisen DJ. Mediastinal tumors: diagnosis and treatment. World J Surg. 2001;25:204–9.Crossref

2.

Fraser RS, Pare JA, Fraser RG, et al. The normal chest. In: Fraser RS, Pare JA, Fraser RG, et al., editors. Synopsis of diseases of the chest. 2nd ed. Philadelphia: W.B. Saunders; 1994. p. 1–116.

3.

Fraser RS, Muller NL, Colman N, et al. The mediastinum. In: Fraser RS, Muller NL, Colman N, et al., editors. Fraser and Pare’s diagnosis of diseases of the chest. 4th ed. Philadelphia: W.B. Saunders; 1999. p. 196–234.

4.

Aroor AR, Prakasha SR, Seshadri S, Teerthanath S, Raghuraj U. A study of clinical characteristics of mediastinal mass. J Clin Diagn Res. 2014;8:77–80.PubMedPubMedCentral

5.

Davis RD, Oldham HN, Sabiston DC. Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg. 1987;44:229.Crossref

6.

Asgary MR, Aghajanzadeh M, Hemmati H, Jafari M. Epidemiology of mediastinal tumors during six years (2006-2012) in Rasht city. Acta Med Mediterranea. 2016;32:1243.

7.

Almeida FA, Kane GC. Approach to mediastinal masses. Pulmon Dis. 2007;12:2–13.

8.

Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest. 2005;128:2893–909.Crossref

9.

Strickler JG, Kurtin PJ. Mediastinal lymphoma. Semin Diagn Pathol. 1991;8:2–13.PubMed

10.

Reeder LB. Neurogenic tumors of the mediastinum. Semin Thorac Cardiovasc Surg. 2000;12:261–7.Crossref

© Springer International Publishing AG, part of Springer Nature 2018

Renato Franco, Federica Zito Marino and Antonio Giordano (eds.)The Mediastinal MassCurrent Clinical Pathologyhttps://doi.org/10.1007/978-3-319-90368-2_2

2. Clinical Approach: Recommendations for the Clinicians

Fortunato Ciardiello¹  , Floriana Morgillo¹   and Giuseppe Viscardi¹  

(1)

Oncology Unit, Department of Precision Medicine, Università della Campania L. Vanvitelli, Naples, Italy

Fortunato Ciardiello

Email: [e-mail]

Floriana Morgillo (Corresponding author)

Email: [e-mail]

Giuseppe Viscardi

Keywords

MediastinalMassSuperior vena cavaMyasthenia gravis

Introduction

Mediastinal masses include a wide variety of entities both neoplastic (benign or malignant, primitive or secondary) and not (infections, trauma, aneurysms, malformations). They may present a spectrum of clinical and pathological features and often pose a diagnostic challenge for clinicians.

Anatomic Distribution

Each compartment of mediastinum can be the origin of specific masses, as summarized in Table 2.1. Primary masses most often found in the anterior compartment are thymic tumors (thymoma, thymic carcinoma, thymic carcinoid tumor, and thymolipoma), thymic cysts, Hodgkin and non-Hodgkin lymphoma , germ cell tumors (seminoma, choriocarcinoma, embryonic carcinoma, teratoma), goiter, parathyroid adenomas and carcinomas, connective tissue tumors and soft tissue sarcomas (e.g., lipomas, liposarcomas, fibroma, fibrosarcoma), and lymphovascular tumors (lymphangioma, lymphangiohemangioma, hemangioma) [1].

Table 2.1

Differential diagnosis of mediastinal mass by compartment

Masses of the middle mediastinum include congenital cysts (bronchogenic cysts, pericardial cysts, and neurenteric cysts), tracheal tumors, aortopulmonary paraganglioma (chemodectoma), and lymphoma. A middle mediastinal mass may also represent lymphadenopathy as a result of infectious, malignant (metastatic), and idiopathic (e.g., sarcoidosis) etiologies [2].

Posterior mediastinum is the site of most neurogenic tumors, meningocele, esophageal lesions (diverticula and tumors), hiatus hernia, and neurenteric cysts [3].

Finally, suppurative acute mediastinitis is usually secondary to either perforation of the esophagus or cardiovascular and endoscopic surgical procedures. Chronic mediastinitis is more rare and may be secondary to tuberculosis infection [4].

Clinical Presentation

In about half of cases, a mediastinal mass can be an incidental finding in patients who undergo imaging studies for other reasons [5].

Local symptoms, if present, may be due to compressive or infiltrative effects of the mass, while systemic symptoms are due to release of hormones, cytokines, and antibodies. In general, malignant lesions are more likely to be symptomatic, and venous compression symptoms precede those of the esophagus or trachea because veins are more easily collapsible.

Symptoms of compression of superior vena cava (SVC). Compression of the superior vena cava may result from the presence of a mass in the middle or anterior mediastinum. Severity of symptoms depends on how quickly the SVC obstruction develops and the degree of narrowing. Acute thrombosis can also occur causing sudden exacerbation of a partial obstruction.

Increased venous pressure causes distention of jugular veins, not changing with respiratory cycle. Edema can be limited to the face or extended to the neck, upper chest, and upper limbs (mantle edema). Venous stasis symptoms (confusion, headache, dizziness) in the cerebral circulation can occur; however, cerebral edema, although rare, can be serious or fatal.

In long-standing cases with 50% or more of SVC stenosis, various collateral channels, depending on the site of obstruction, are formed to restore venous return to the right atrium. Most of the patients with pre-azygos obstruction of the SVC remain asymptomatic for a long period of time, because in these conditions the right superior intercostal veins serve as the collateral pathway. When the azygos vein is also obstructed, the collateral circulation establishes between the SVC and IVC via minor communicating channels, i.e., internal mammary veins; thus, signs of venous stasis are more pronounced [6].

Clinical and radiological scoring systems of SVC syndrome have been proposed. In the case of a malignancy causing SVC obstruction, management issues include surgical, medical, or radiotherapy treatment of the malignancy itself and palliative treatments for the symptoms. Traditional medical treatment such as corticosteroids and diuretics is not supported by data demonstrating benefit [7].

Symptoms of compression of esophagus: dysphagia. Paraesophageal lymph node metastasis from lung cancer is a frequent cause of dysphagia.

Symptoms of compression of trachea: dyspnea, inspiratory stenotic noises, and reentry of intercostal and suvraclavear spaces appear below a critical threshold of 50% of normal diameter. The worsening of the tracheal compression causes stagnation of secretions and coughs.

Neurological symptoms can be caused by compression of phrenic nerves (hiccup, paralysis of hemi diaphragm), recurrent laryngeal nerve (dysphonia; the left recurrent laryngeal nerve is the most frequently affected, due to its longer course), or vague nerves (heart rhythm alterations, digestive symptoms as nausea, vomiting, and diarrhea). Sympathetic chain compression in paravertebral region leads to miosis and enophthalmus (Horner’s syndrome).

Systemic symptoms. Most common paraneoplastic syndrome associated with thymoma is myasthenia gravis (MG) , followed by hypogammaglobulinemia and pure red cell aplasia. Autoimmune disorders such as systemic lupus erythematosus, polymyositis, and myocarditis may also be associated with thymoma. However, lack of myasthenia gravis does not rule out thymoma [8]. Clinical presentation of lymphoma can include B symptoms such as fever, night sweats, or weight loss. Furthermore, syndromes and symptoms caused by the production of hormones by primitive neoformations of the mediastinum (ACTH, thyroid hormones, PTH, catecholamines, etc.) can be present (Table 2.2).

Table 2.2

Syndromes and symptoms due to hormone production or paraneoplastic syndromes

Presumptive Clinical Diagnosis

In most patients, a combination of demographic information, clinical presentation, and imaging features allows a presumptive diagnosis (Table 2.3). All patients should have a detailed history and physical examination before a major work-up is initiated.

Epidemiology. Age and gender of the patient help predict the etiology of a mediastinal mass, as specific conditions are more common in certain demographic groups [9]. In infants and children, neurogenic tumors and enterogenous cysts are the most common mediastinal masses, while in adults thyroid goiter and thymic malignancies are most frequent encountered lesions. Since both Hodgkin’s and non-Hodgkin’s lymphoma and germ cell tumors are most common between the ages of 20 and 40, the likelihood of a mediastinal mass being malignant is increased among these patients. Also benign teratoma is relatively common in this age group.

Physical examination. Enlarged lymph nodes in the cervical, supraclavicular, and axillary regions may be palpable. A palpable cervical mass may suggest mediastinal extension of a cervical goiter. Pleuropulmonary (pleural effusion) or abdominal (hepatomegaly and/or splenomegaly) signs may be additional findings.

In suspecting a germ cell tumor, a testicular examination should be done in all male patients. Clinical signs of diseases such as neurofibromatosis or Klinefelter syndrome can address the diagnosis. Multiple neurogenic tumors and plexiform neurofibroma are typical findings of neurofibromatosis .

Laboratory tests. Increased levels of alpha-fetoprotein (AFP) are typically found in non-seminomatous tumors (embryonal carcinoma and yolk sac). Elevated serum levels of human chorionic gonadotropin (HCG) are present in choriocarcinoma [10].

Lactate dehydrogenase (LDH) is a less-specific marker, reflecting the growth rate and tumor burden. Increased levels of serum LDH have been reported in approximately 80% of advanced seminomas and in about 60% of non-seminomas. Serum LDH is commonly elevated also in lymphoproliferative disorders .

Pre-chemotherapy levels of LDH, AFP, or HCG have also been integrated into the International Germ Cell Cancer Consensus Group (IGCCCG) prognostic index for non-seminoma classification.

In approximately 85% of MG patients, circulating antibodies against the acetylcholine receptor (AChR) are not only the pathogenic effector immune molecules but also provide a diagnostic test.

Imaging. Most mediastinal abnormalities are first detected by standard posteroanterior and lateral chest radiographs. It is rarely diagnostic but provides information on the mediastinum profile, any calcific or bone formations, or levels between the various components (solid, fluid, aerial) of the mass.

Whenever a mediastinal mass is detected on plain films, a computed tomography (CT) scan of the chest is generally indicated. It allows to define seat, size, density, and relationship with anatomical structures of thorax. It also guides further biopsy diagnostic tests. Diagnosis can be suggested based on components of the mass: cystic, fatty, or solid tissue.

Chest wall study and assessment of relationships with pericardium, spinal cord, and canal are the major indication for magnetic resonance imaging (MRI) of the mediastinum. Also, MRI provides better soft tissue differentiation than CT, useful in characterization of cysts and adenomas and differentiation of postsurgical or post-actinic fibrosis from disease relapse. MRI should be considered in patients who cannot receive iodinated intravenous contrast [11].

18F-FDG PET is not routinely performed to evaluate or characterize a mediastinal mass but is typically used to stage lymphomas and monitor response to therapy.

Table 2.3

Diagnostic approach to mediastinal masses

Tissue Diagnosis

In a proportion of patients with a mediastinal mass, a presumptive clinical diagnosis cannot be reached, and biopsy is mandatory for diagnosis and/or treatment plain [12].

The histological diagnosis of a mediastinal tumor is always important, even in cases of inoperable disease, in order to evaluate the most appropriate therapeutic choice. Various methods can be used, which differ in the access path and picking technique, depending on location, size, and diagnostic suspect.

The cytological examination can be performed as CT-guided percutaneous fine needle aspiration, while agobiopsy remains the preferable option to obtain a tissue fragment. The access route may also be mininvasive surgical (by videothoracoscopy or mediastinoscopy). Anterior mediastinotomy or thoracotomy can be necessary in some cases.

Differential Diagnosis

Middle Mediastinal Mass

Lymphoma is one of the most common primary mediastinal tumors , representing 10–15% of mediastinal masses and presents more often as generalized disease. Only 10% of lymphomas involving mediastinum are primary, and the majority are Hodgkin lymphomas (~70%). The three most common types of mediastinal lymphoma include nodular sclerosing HD, large B-cell lymphoma, and lymphoblastic lymphoma [13].

Primary mediastinal B-cell lymphoma (PMBCL) is a diffuse large B-cell non-Hodgkin lymphoma that arises in the thymus, now identified as distinct clinicopathologic entity.

Lymphoproliferative disorders include also Castleman disease . It might be localized or multicentric and usually involves the mediastinum. Multicentric Castleman disease (MCD) involves hyperactivation of the immune system, excessive release of cytokines leading to systemic symptoms, and multiple organ system dysfunctions [14]. IL-6 is the most commonly elevated cytokine, and its release is caused in 50% of cases by infection with human herpesvirus 8 (HHV-8), whose DNA can be detected in peripheral blood by polymerase chain reaction (PCR) .

Other causes of lymphadenopathy are infections, metastases, and idiopathic diseases (sarcoidosis).

Tuberculosis lymphadenopathy is another hypothesis in patients with middle mediastinal mass. Cervical region is more frequently involved, followed by mediastinal lymph nodes. In developed countries majority of patients are immigrants. Also in this case, systemic symptoms, such as fever, night sweats, and weight loss, can be present. The best diagnostic approach appears to be a combination of skin testing and FNA, since most HIV-seronegative patients are PPD-positive.

Developmental cysts account for 15% of mediastinal masses. They present as well-circumscribed masses with a smooth wall. The most common type of mediastinal cyst is foregut cysts, with enterogenous cysts (50–70%) and bronchogenic cysts (7–15%) being the most common subtypes. Pericardial cysts are part of a larger group of mesothelial cysts; the most common is at the right cardiophrenic angle. Neurenteric cysts are characterized by the presence of both enteric and neural tissue. Most of these cysts form in the posterior mediastinum above the level of the main carina [15].

Anatomical variants as vascular anomalies (aneurysm) or masses arising from digestive tract (hiatal hernia) can be radiologically recognized.

Anterior Mediastinal Mass

The classification of thymic neoformations includes thymic hyperplasia, thymic cysts, thymoma, thymolipoma, and thymic carcinoid. The last two are very rare. The typical seat is the upper anterior mediastinum.

Thymic neoplasms , predominantly thymomas, constitute the 30 and 50% of anterior mediastinal masses in adults and children, respectively. No specific etiology or risk factors are known but a well-known association with myasthenia gravis does exist. Only a small part of thymoma patients is affected by myasthenia, while about 20% of myasthenic patients are affected by thymoma.

Ninety percent of thymomas occur in the anterior mediastinum, the reminder in the neck or other areas of the mediastinum. Classification is based on cell-type predominance as lymphocytic, epithelial, or spindle cell variants. Thymomas may be encapsulated or frankly invasive. A strong association between histologic subtype and invasiveness as well as prognosis is known.

Chest pain, cough, and dyspnea are the most common symptoms due to local growth. Metastatic disease is uncommon and can occur in pleural implants or pulmonary nodules.

Thymic carcinomas are aggressive malignancies. Their incidence is rare, occurring predominantly in middle-aged men. They often manifest as large, poorly defined, infiltrative mass that frequently metastasizes to regional lymph nodes and distant sites [16].

In anterior mediastinum prevascular and paratracheal lymph nodes are the most common localizations of lymphoma .

Primary mediastinal goiters (PMG) are very uncommon. Cervical goiters may descend into the thorax in 10% of cases, generally into the left anterior superior mediastinum. The most common symptoms are cervical mass, dysphagia, and dyspnea. Ten percent of patients are asymptomatic.

Germ cell tumors . Mediastinal germ cell (MGC) neoplasms account for 2–5% of germ cell tumors but constitute more than half of extragonadal tumors. They are responsible for 10–15% of mediastinal primary tumors. They can occur at any age but most commonly between the third and fifth decade of life.

Benign neoplasms include mature and mixed teratomas (with an immature component of less than 50%). Among these, benign teratomas are the most common MGC tumor; the majority of them contain variable amounts of mature ectodermal, mesodermal, and endodermal elements and exhibit a benign course. Mature teratomas have the potential in rare circumstances to undergo malignant transformation.

Malignant germ cell tumors are divided into seminomatous and non-seminomatous tumors. Primary mediastinal seminomas , although uncommon, comprise 25–50% of malignant mediastinal GCTs. On radiological imaging seminomas appear as bulky lobulated and homogeneous mass. Choriocarcinomas, yolk sac tumors, immature teratomas, and embryonal carcinomas are classified together as non-seminomatous. Radiologically they are large, irregular masses frequently with areas of low attenuation due to necrosis or hemorrhage.

Many patients with benign tumors are asymptomatic, whereas most of patients with malignant MGC have symptoms of chest pain, cough, dyspnea, and fever due to compression and invasion of surrounding structures. Gynecomastia can develop as a result of β-hCG secretion. Pulmonary metastases are present in 60–70% of patients.

Measuring AFP and β-hCG levels is important in making the diagnosis and follow-up [17]. Only 10% of parathyroid adenomas are ectopic, and almost half occur in the anterior mediastinum, near or within the thymus. It generally causes hyperparathyroidism , resulting in hypercalcemia . These tumors are encapsulated, round, and usually <3 cm in size. MRI or nuclear scans with 99m Tc and 201 Ti are more effective than CT scan for the diagnosis of parathyroid adenomas .

Posterior Mediastinal Mass

Neurogenic tumors represent approximately 20% of all adult mediastinal neoplasms. They can arise from neural cells in any location; however, they commonly are found in the posterior compartment of mediastinum, at costovertebral angle. About 10% of neurogenic tumors extend for contiguity in the vertebral canal through the spinal foramina.

Neurogenic tumors can be benign or malignant, with a wide array of both clinical and pathologic features; classification is based on cell type of origin. Adults have a lower rate of malignancy (5–10% in adults compared with 40–60% in children). Schwannoma and neurofibroma are the most common neurogenic tumors in adults; they arise from the nerve sheath and appear on imaging studies as well-circumscribed, spherical, lobulated paraspinous masses. A significant proportion of cases are asymptomatic and discovered incidentally. Symptomatic cases present with chest pain, cough, or compression symptoms, in particular in tumors extending through spinal foramina. Up to 45% of neurofibromas occur in patients with neurofibromatosis type I (von Recklinghausen’s disease; NF1); in this setting, the tumors occur at a younger age and are often multiple. Plexiform neurofibroma is pathognomonic for NF1 and carries a risk of transformation to malignant peripheral nerve sheath tumor (MPNST) . In pediatric populations the cells of origin are those involved in the development of sympathetic nervous system, ranging from benign ganglioneuromas to malignant neuroblastoma and, the intermediate form, ganglioneuroblastoma. Neuroblastoma is the most common extracranial solid tumor of infancy, and in 20% of cases, it originates in the chest. Neuroblastoma has a high propensity to produce vasoactive substances that can cause hypertension, flushing, and diarrhea; measurement of urinary metabolites of catecholamines (vanillylmandelic acid, VMA, and homovanillic acid, HVA) can also help the diagnosis. Neuron-specific enolase (NSE)-elevated levels can be demonstrated in most patients with metastases. Metaiodobenzylguanidine (MIBG) is an analog of norepinephrine taken up specifically by catecholaminergic cells, so scintigraphy using iodine-123-marked MIBG can help to detect metastatic disease in bones as well as in soft tissue. Modern management is tailored to the risk stratification of individual patients according to International Neuroblastoma Staging System (INSS) [18].

Spinal meningocele is a saccular protrusion, containing cerebrospinal fluid, of the meninges through intervertebral foramina or bone defects in one or more vertebrae. Most meningoceles are associated with syndromes, such as neurofibromatosis type 1.Small meningoceles are asymptomatic, whereas larger lesions may compress the spinal cord, spinal nerves, and adjacent mediastinal structures.

References

1.

Priola AM, Priola SM, Cardinale L, et al. The anterior mediastinum: diseases. Radiol Med. 2006;111(3):312–42.Crossref

2.

Kim Y, Lee KS, Yoo JH, et al. Middle mediastinal lesions: imaging findings and pathologic correlation. Eur J Radiol. 2000;35(1):30–8.Crossref

3.

Occhipinti M, Heidinger BH, Franquet E, et al. Imaging the posterior mediastinum: a multimodality approach. Diagn Interv Radiol. 2015;21(4):293–306.Crossref

4.

Athanassiadi KA. Infections of mediastinum. Thorac Surg Clin. 2009;19(1):37–45.Crossref

5.

Davis RD Jr, Oldham HN Jr, Sabiston DC Jr. Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg. 1987;44(3):229–37.Crossref

6.

Wilson LD, Detterbeck FC, Yahalom J. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007;356:1862–9.Crossref

7.

Cohen R, Mena D, Carbajal-Mendoza R, et al. Superior vena cava syndrome: a medical emergency? Int J Angiol. 2008;17(1):43–6.Crossref

8.

Shelly S, Levin NA, Altman A, et al. Thymoma and autoimmunity. Cell Mol Immunol. 2011;8(3):199–202.Crossref

9.

Azarow KS, Pearl RH, Zurcher R, et al. Primary mediastinal masses: a comparison of adult and pediatric populations. J Thorac Cardiovasc Surg. 1993;106:67.PubMed

10.

Barlow LJ, Badalato GM, McKiernan JM. Serum tumor markers in the evaluation of male germ cell tumors. Nat Rev Urol. 2010;7(11):610–7.Crossref

11.

Takahashi K, Al-Janabi NJ. Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging. 2010;32(6):1325–39.Crossref

12.

Gupta S, Seaberg K, Wallace MJ, et al. Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations. Radiographics. 2005;25(3):763–86.Crossref

13.

Strickler JG, Kurtin PJ. Mediastinal lymphoma. Semin Diagn Pathol. 1991;8:2–13.PubMed

14.

Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128(8):657–62.Crossref

15.

Takeda S, Miyoshi S, Minami M, et al. Clinical spectrum of mediastinal cysts. Chest. 2003;124:125–32.Crossref

16.

Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest. 2005;128(4):2893–909.Crossref

17.

Hainsworth J. Diagnosis, staging, and clinical characteristics of the patient with mediastinal germ cell carcinoma. Chest Surg Clin N Am. 2002;12:665–72.Crossref

18.

Reeder LB. Neurogenic tumors of the mediastinum. Semin Thorac Cardiovasc Surg. 2000;12(4):261–7.Crossref

© Springer International Publishing AG, part of Springer Nature 2018

Renato Franco, Federica Zito Marino and Antonio Giordano (eds.)The Mediastinal MassCurrent Clinical Pathologyhttps://doi.org/10.1007/978-3-319-90368-2_3

3. Mediastinal Masses: Radiological Point of View

Alfonso Reginelli¹  , Anna Russo¹  , Fernando Scala¹  , Elisa Micheletti¹  , Roberta Grassi²  , Mario Santini³   and S. Cappabianca¹  

(1)

Radiology and Radiotherapy Unit, Department of Clinical and Experimental Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy

(2)

Radiotherapy Unit, Department of Biomedical, Experimental and Clinical Sciences Mario Serio, University of Florence, Florence, Italy

(3)

Thoracic Surgery Unit, Department of Translational Medical Science, Università degli Studi della Campania ‘Luigi Vanvitelli’, Naples, Italy

Alfonso Reginelli (Corresponding author)

Email: [e-mail]

Anna Russo

Email: [e-mail]

Fernando Scala

Email: [e-mail]

Elisa Micheletti

Email: [e-mail]

Roberta Grassi

Email: [e-mail]

Mario Santini

Email: [e-mail]

S. Cappabianca

Email: [e-mail]

Keywords

MediastinumMediastinal massesPrevascular compartmentVisceral compartmentParavertebral compartment

Introduction

Mediastinal masses are relatively uncommon [1]. Because such a wide variety of other pathologic entities can occur in this region, radiologists and clinicians will encounter many of these specific lesions only infrequently. Imaging is a critical part of establishing a presumptive diagnosis, which is used to guide whether and what type of confirmatory testing is needed. When classic features are present, a presumptive diagnosis can be made with a high degree of confidence based on imaging alone. Developing an appropriate differential diagnosis for a particular patient can be very useful in avoiding unnecessary and sometimes misleading biopsies or additional tests. The mediastinum contains vital vascular and nonvascular structures and organs [2, 3]. In many instances, localization and characterization of a mediastinal abnormality using multidetector CT are enough to make a diagnosis. In other cases, correlation between imaging findings and clinical context, as well as additional imaging examinations (such as MR imaging and fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT and histologic sampling through image guided or surgical biopsy), is necessary to make a definitive diagnosis and guide further management. Employing the existing nomenclature of the mediastinal compartments, slightly more than half of all mediastinal masses are located in the anterior compartment, whereas one fourth are identified in the middle and posterior mediastinal compartments. Division of the mediastinum into specific compartments has traditionally been valuable in the identification, characterization, and management of various mediastinal abnormalities [4].

The existing schemes used in radiologic practice represent arbitrary non-anatomic divisions of the chest, primarily based on the lateral chest radiograph. Division of the mediastinum into specific compartments is favorable for a number of reasons, including the generation of a focused differential diagnosis, assistance in planning for biopsies and surgical procedures, and the facilitation of communication between clinicians in a multidisciplinary setting. Several classification schemes for the mediastinum have been created and used. Most radiologic classifications have been based on arbitrary landmarks outlined on the lateral chest radiograph. A new scheme, based on cross-sectional imaging (principally multidetector computed tomography ), has been developed by the International Thymic Malignancy Interest Group (ITMIG) and accepted as the new standard. This clinical division scheme defines unique prevascular, visceral, and paravertebral compartments based on boundaries delineated by specific anatomic structures at multidetector CT [4]. This new definition plays an important role in the identification and characterization of mediastinal abnormalities , which can often be diagnosed with confidence, based on their location and imaging features alone. In other cases, a diagnosis maybe suggested when radiologic features are combined with specific clinical information. This new definition plays an important role in the identification and characterization of mediastinal abnormalities, which, although uncommon and encompassing a wide variety of entities, can often be diagnosed with confidence based on location and imaging features alone. The three compartment cross-sectional imaging model developed by ITMIG includes prevascular (anterior), visceral (middle), and paravertebral (posterior) sections. Specific compartment boundaries and the anatomic structures contained can be readily identified at multidetector CT.

Radiological Anatomy

Prevascular Compartment

The following boundaries of the prevascular compartment are defined as (a) superiorly, the thoracic inlet; (b) inferiorly, the diaphragm; (c) anteriorly, the posterior border/cortex of the sternum; (d) laterally, the parietal mediastinal pleura; and (e) posteriorly, the anterior aspect of the pericardium as it wraps around the heart in a curvilinear shape. The major contents of the prevascular compartment include the thymus, fat, lymph nodes, and the left brachiocephalic vein [5–10]. Therefore, the most common abnormalities encountered in the prevascular compartment include thymic lesions (cysts, hyperplasia, and malignancies such as thymomas, thymic carcinomas, and neuroendocrine neoplasms), germ cell neoplasms (which derive from germ cell rest remnants in the mediastinum), lymphomas, metastatic lymphadenopathies, and intrathoracic goiters.

Visceral Compartment

The following boundaries of the visceral compartment are defined: (a) superiorly, the thoracic inlet; (b) inferiorly, the diaphragm; (c) anteriorly, the posterior boundaries of the prevascular compartment; and (d) posteriorly, a vertical line connecting a point on the thoracic vertebral bodies 1 cm posterior to the anterior margin of the spine (referred to as the visceral paravertebral compartment boundary line). The major contents of the visceral compartment can be divided into two main categories: (a) vascular structures including the heart, superior vena cava, ascending thoracic aorta, aortic arch, descending thoracic aorta, intrapericardial pulmonary arteries, and thoracic duct and (b) nonvascular structures including the trachea, carina, esophagus, and lymph nodes. The most common abnormalities in the visceral compartment include lymphadenopathies (related to lymphomas or metastatic disease), duplication cysts, tracheal lesions, and esophageal neoplasms. Additionally, vascular lesions deriving from the heart, pericardium, and great vessels may also be present.

Paravertebral Compartment

The following boundaries of the paravertebral compartment are defined: (a) superiorly, the thoracic inlet; (b) inferiorly, the diaphragm; (c) anteriorly, the posterior boundaries of the visceral compartment; and (d) posterolaterally, a vertical line along the posterior margin of the chest wall at the lateral side of the transverse processes. The major contents of the paravertebral compartment include the thoracic spine and paravertebral soft tissues; therefore, most abnormalities in this region are neurogenic neoplasms that arise from the dorsal root ganglia/neurons adjacent to the intervertebral foramina [8–11]. Other potential